A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03981536 · UNKNOWN

Trial details

NCT number: NCT03981536
Sponsor: AL-S Pharma
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2019-10-10
Primary completion: 2020-11-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.